Modeling Heterogeneity in Patients' Preferences for Psoriasis Treatments in a Multicountry Study: A Comparison Between Random-Parameters Logit and Latent Class Approaches

被引:20
作者
Boeri, Marco [1 ]
Saure, Daniel [2 ]
Schacht, Alexander [2 ]
Riedl, Elisabeth [3 ]
Hauber, Brett [4 ]
机构
[1] RTI Hlth Solut, Hlth Preference Assessment, Forsyth House,Cromac Sq, Belfast BT2 8LA, Antrim, North Ireland
[2] Eli Lilly & Co, Bad Homburg, Germany
[3] Eli Lilly & Co, Vienna, Austria
[4] RTI Hlth Solut, Hlth Preference Assessment, Res Triangle Pk, NC USA
关键词
DISCRETE-CHOICE EXPERIMENTS; DRUG-TREATMENT; HEALTH; RISKS; REGRESSION; BENEFITS; MODERATE; NEED;
D O I
10.1007/s40273-020-00894-7
中图分类号
F [经济];
学科分类号
02 ;
摘要
Background Either a random-parameters logit (RPL) or latent class (LC) model can be used to model or explain preference heterogeneity in discrete-choice experiment (DCE) data. The former assumes continuous distribution of preferences across the sample, while the latter assumes a discrete distribution. This study compared RPL and LC models to explore preference heterogeneity when analyzing patient preferences for psoriasis treatments. Methods Using DCE data collected from respondents with moderate-to-severe plaque psoriasis, we calculated and compared preference weights derived from RPL and LC models. We then compared how RPL and LC explain preference heterogeneity by exploring differences across subgroups defined by observed characteristics (i.e., country, age, gender, marital status, and psoriasis severity). Results While RPL and LC models resulted in the same mean preference weights, different preference-heterogeneity patterns emerged from the two approaches. In both models, country of residence and self-reported disease severity could be linked to systematic differences in preferences. The RPL also identified gender and marital status, but not age, as sources of heterogeneity; the LC membership probability model indicated that age was a significant factor, but not gender or marital status. Conclusions Using data from a psoriasis patient survey to compare two widely used methods for exploring heterogeneity identified differences in results between stated-preferences: subgroup analysis in the RPL model and inclusion of subgroup characteristics in the class membership probability function of the LC model. Researchers should model data using the most adaptable approach to address the initial study question.
引用
收藏
页码:593 / 606
页数:14
相关论文
共 44 条
  • [1] Dermatologist and Patient Preferences in Choosing Treatments for Moderate to Severe Psoriasis
    Alcusky, Matthew
    Lee, Seina
    Lau, Gordon
    Chiu, Gretchen R.
    Hadker, Nandini
    Deshpande, Aparna
    Fleming, Stephen
    Vance, Nicola
    Fakharzadeh, Steve
    [J]. DERMATOLOGY AND THERAPY, 2017, 7 (04) : 463 - 483
  • [2] Trade-offs between the benefits and risks of drug treatment for psoriasis: a discrete choice experiment with UK dermatologists
    Ashcroft, D. M.
    Seston, E.
    Griffiths, C. E. M.
    [J]. BRITISH JOURNAL OF DERMATOLOGY, 2006, 155 (06) : 1236 - 1241
  • [3] The unmet treatment need for moderate to severe psoriasis: results of a survey and chart review
    Christophers, E.
    Griffiths, C. E. M.
    Gaitanis, G.
    van de Kerkhof, P.
    [J]. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2006, 20 (08) : 921 - 925
  • [4] Discrete Choice Experiments in Health Economics: A Review of the Literature
    Clark, Michael D.
    Determann, Domino
    Petrou, Stavros
    Moro, Domenico
    de Bekker-Grob, Esther W.
    [J]. PHARMACOECONOMICS, 2014, 32 (09) : 883 - 902
  • [5] Modeling Organizational Justice Improvements in a Pediatric Health Service
    Cunningham, Charles E.
    Kostrzewa, Linda
    Rimas, Heather
    Chen, Yvonne
    Deal, Ken
    Blatz, Susan
    Bowman, Alida
    Buchanan, Don H.
    Calvert, Randy
    Jennings, Barbara
    [J]. PATIENT-PATIENT CENTERED OUTCOMES RESEARCH, 2013, 6 (01) : 45 - 59
  • [6] Discrete choice experiments in health economics: a review of the literature
    de Bekker-Grob, Esther W.
    Ryan, Mandy
    Gerard, Karen
    [J]. HEALTH ECONOMICS, 2012, 21 (02) : 145 - 172
  • [7] What is clearance worth? Patients' stated risk tolerance for psoriasis treatments
    Fairchild, Angelyn O.
    Reed, Shelby D.
    Johnson, F. Reed
    Anglin, Greg
    Wolka, Anne M.
    Noel, Rebecca A.
    [J]. JOURNAL OF DERMATOLOGICAL TREATMENT, 2017, 28 (08) : 709 - 715
  • [8] Feldman Steven R, 2017, J Health Econ Outcomes Res, V4, P141, DOI 10.36469/9817
  • [9] Comparing preferences for outcomes of psoriasis treatments among patients and dermatologists in the UK: results from a discrete-choice experiment
    Gonzalez, J. M.
    Johnson, F. R.
    McAteer, H.
    Posner, J.
    Mughal, F.
    [J]. BRITISH JOURNAL OF DERMATOLOGY, 2017, 176 (03) : 777 - 785
  • [10] A latent class model for discrete choice analysis: contrasts with mixed logit
    Greene, WH
    Hensher, DA
    [J]. TRANSPORTATION RESEARCH PART B-METHODOLOGICAL, 2003, 37 (08) : 681 - 698